RSS   Newsletter   Contact   Advertise with us

AstraZeneca appoints Michel Demare to board

Share on Twitter Share on LinkedIn
Christian Fernsby | London, United Kingdom | August 19, 2019
Michel DemareAstraZeneca announced that Michel Demare is appointed as a non-executive director and a member of the audit committee with effect from 1 September 2019.
Mr. Demare is a Non-Executive Director of Vodafone Group Plc and a member of the Supervisory Board of Louis Dreyfus Company Holdings BV.

He is Vice-Chairman and Chairman-designate of the IMD executive business school in Lausanne, and a member of the Advisory Board of the Department of Banking and Finance at the University of Zurich.

Mr. Demare was Vice-Chairman of UBS Group AG from 2010 to 2019, Chairman of Syngenta and the Syngenta Foundation for Sustainable Agriculture from 2013 to 2017 and Chairman of SwissHoldings from 2013 to 2015.

Mr. Demaree joined ABB Ltd in 2005 as Chief Financial Officer (CFO) and member of the Group Executive Committee.

For most of 2008, he acted as the interim Chief Executive Officer of ABB. From late 2008 to 2011, he combined his role as CFO with that of President of Global Markets.

Mr. Demare joined ABB from Baxter International Inc., where he was CFO Europe from 2002 to 2005.

Prior to that, Mr. Demare spent 18 years at the Dow Chemical Company, holding various treasury and risk management positions in Belgium, France, the US and Switzerland.

Between 1997 and 2002, Mr. Demare was CFO of the Global Polyolefins and Elastomers division.

Mr. Demare began his career as a banking officer in the multinational banking division of Continental Illinois’ Belgian subsidiary.

Mr. Demare graduated with an MBA from the Katholieke Universiteit Leuven, Belgium, and holds a degree in applied economics from the Universite Catholique de Louvain, Belgium. â– 

 LATEST MOVES FROM United Kingdom